Merck Revised to $50 on Strong Pipeline
Merck Revised To On Strong Pipeline
Filed under: drug treatment news 2012
The company saw Singulair, the asthma drug that is one of its biggest sellers with nearly $ 5.5 billion revenue in 2011, lose its U.S. patent protection in August 2012. The drug has witnessed a faster than expected decline in revenues post patent expiry …
Read more on Forbes
Biogen Idec Announces 3rd Collaboration of 2012 with Isis Pharmaceuticals
Filed under: drug treatment news 2012
They have entered into agreement on a global collaboration effort under which the companies will discover and develop several antisense drugs to treat neurological and neuromuscular disorders. The two companies have a previously established working …
Read more on Guardian Express
2012: The Year in Almosts, Not-Quites, and Nearly-Theres
Filed under: drug treatment news 2012
He grounded his explanation in the logic of economics as much as morality. “It costs us $ 49,000 a year to warehouse a prisoner in New Jersey state prisons last year,” he explained to the crowd. “A full year of inpatient drug treatment costs $ 24,000 a …
Read more on New Yorker (blog)
Compact Proton Therapy Technology from ProTom International, Inc. Achieves …
Filed under: drug treatment news 2012
Compact Proton Therapy Technology from ProTom International, Inc. Achieves Scheduled December 2012 Milestone of Beam at Gantry Room Isocenter. FLOWER MOUND, Texas & FLINT, Mich. –. Testing of a compact cancer-treatment technology from …
Read more on Fort Mills Times